Co-prescription of the anticonvulsant gabapentin is associated with an increased risk of opioid-related death in people who are prescribed opioid painkillers, according to a new study published in PLOS Medicine.
Oct 3, 2017
0
5
Existing evidence on the use of gabapentinoids in chronic low back pain (CLBP) is limited, and demonstrates significant risk of adverse effects with no benefits on pain relief, according to a meta-analysis published in PLOS ...
Aug 15, 2017
0
2
A multi-disciplinary study has shown that the recent substantial increase in prescriptions for two drugs, pregabalin and gabapentin, used widely for a range of neurological disorders is closely correlated with a rise in the ...
May 11, 2017
1
2
(HealthDay News) —Needles beat pills for treating hot flashes in breast cancer survivors, according to a new trial that compared acupuncture, "sham" acupuncture, the medication gabapentin and a placebo pill.
Aug 25, 2015
0
258
Pregnant women with hyperemesis gravidarum, the extreme and debilitating form of morning sickness that Kate Middleton, Duchess of Cambridge, famously experienced, may find relief from a medication prescribed for seizure patients.
Jun 19, 2014
0
1
(HealthDay)—Preoperative pregabalin is superior to either gabapentin or placebo for the relief of pain in patients undergoing lumbar discectomy, according to a study published in the March 15 issue of Spine.
Mar 28, 2014
0
0
(HealthDay)—The addition of gabapentin to patient-controlled analgesia (PCA) protocol does not reduce morphine consumption, pain, or opioid-related side effects in patients undergoing total knee arthroplasty, according ...
Nov 27, 2013
0
0
The generic drug gabapentin, which is already widely prescribed for epilepsy and some kinds of pain, appears to be safe and effective in the treatment of alcohol dependence. The finding comes from a 150-patient randomized, ...
Nov 4, 2013
0
0
(HealthDay)—People suffering from restless legs syndrome may find some relief by taking one of several drugs approved to treat the condition, a new review confirms.
Mar 4, 2013
0
0
Discrepancies between internal and published analyses of industry-sponsored clinical trials lead to further calls for transparency
Jan 29, 2013
0
0
